Tercica up on Insmed settlement

TRCA gained $1 (20%) to $5.88 on Wednesday after it and INSM announced late Tuesday that they have agreed to settle all outstanding litigation, including patent infringement lawsuits brought

Read the full 295 word article

How to gain access

Continue reading with a
two-week free trial.